SEC 13F Intelligence

Foresite Capital Management Vi LLC / RAPT

Foresite Capital Management Vi LLC’s Rapt Therapeutics Inc Position

Does Foresite Capital Management Vi LLC own Rapt Therapeutics Inc (RAPT)? Not currently — the last reported position was 1.56M shares worth $53M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$53M
Q4 2025
Shares
1.56M
% of Portfolio
+16.00%
Quarters Held
3
position exited

Position History RAPT

Reported value by quarter
Q2 ’25: $13MQ2 ’25Q3 ’25: $40MQ3 ’25Q4 ’25: $53MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20251.56M$53M+16.00%
Q3 20251.56M$40M+15.57%
Q2 20251.56M$13M+7.03%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of RAPT.